This company listing is no longer active
Laboratorio Reig Jofre Toekomstige groei
Future criteriumcontroles 4/6
Laboratorio Reig Jofre is forecasted to grow earnings and revenue by 26.6% and 5.5% per annum respectively. EPS is expected to grow by 26.4%. Return on equity is forecast to be 8.5% in 3 years.
Belangrijke informatie
26.6%
Groei van de winst
26.4%
Groei van de winst per aandeel
Pharmaceuticals winstgroei | 15.3% |
Inkomstengroei | 5.5% |
Toekomstig rendement op eigen vermogen | 8.5% |
Dekking van analisten | Low |
Laatst bijgewerkt | n/a |
Recente toekomstige groei-updates
Geen updates
Recent updates
Geen updates
Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2024 | 291 | 14 | 17 | 35 | 1 |
12/31/2023 | 279 | 12 | 14 | 31 | 1 |
12/31/2022 | 261 | 7 | 4 | 19 | 1 |
12/31/2021 | 240 | 5 | -5 | 14 | N/A |
9/30/2021 | 237 | 6 | N/A | N/A | N/A |
6/30/2021 | 234 | 6 | 9 | 26 | N/A |
3/31/2021 | 234 | 6 | N/A | N/A | N/A |
12/31/2020 | 234 | 6 | 7 | 19 | N/A |
9/30/2020 | 229 | 8 | N/A | N/A | N/A |
6/30/2020 | 229 | 6 | -15 | 14 | N/A |
3/31/2020 | 219 | 6 | N/A | N/A | N/A |
12/31/2019 | 206 | 5 | -19 | 12 | N/A |
9/30/2019 | 199 | 7 | N/A | N/A | N/A |
6/30/2019 | 188 | 9 | -10 | 16 | N/A |
3/31/2019 | 188 | 9 | N/A | N/A | N/A |
12/31/2018 | 185 | 9 | -6 | 15 | N/A |
9/30/2018 | 185 | 10 | N/A | N/A | N/A |
6/30/2018 | 179 | 9 | -4 | 14 | N/A |
3/31/2018 | 175 | 9 | N/A | N/A | N/A |
12/31/2017 | 172 | 9 | 3 | 21 | N/A |
9/30/2017 | 164 | 5 | N/A | N/A | N/A |
6/30/2017 | 164 | 7 | -6 | 8 | N/A |
3/31/2017 | 164 | 8 | N/A | N/A | N/A |
12/31/2016 | 161 | 8 | -14 | -1 | N/A |
9/30/2016 | 160 | 5 | N/A | N/A | N/A |
6/30/2016 | 159 | 5 | -4 | 8 | N/A |
3/31/2016 | 156 | 5 | N/A | N/A | N/A |
12/31/2015 | 157 | 9 | 2 | 13 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: RJF.D's forecast earnings growth (26.6% per year) is above the savings rate (0.9%).
Winst versus markt: RJF.D's earnings (26.6% per year) are forecast to grow faster than the Spanish market (10.3% per year).
Hoge groeiwinsten: RJF.D's earnings are expected to grow significantly over the next 3 years.
Omzet versus markt: RJF.D's revenue (5.5% per year) is forecast to grow faster than the Spanish market (3% per year).
Hoge groei-inkomsten: RJF.D's revenue (5.5% per year) is forecast to grow slower than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: RJF.D's Return on Equity is forecast to be low in 3 years time (8.5%).